caffeine has been researched along with Cerebrovascular Disorders in 20 studies
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite significant progress in understanding of the potential of adenosine A1 receptor-based therapies in treatment of cerebral ischemia and stroke, very little is known about the effect of selective stimulation of adenosine A2A receptors on the outcome of a cerebrovascular arrest." | 7.69 | Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist. ( Jacobson, KA; Lin, RC; Von Lubitz, DK, 1995) |
| "Despite significant progress in understanding of the potential of adenosine A1 receptor-based therapies in treatment of cerebral ischemia and stroke, very little is known about the effect of selective stimulation of adenosine A2A receptors on the outcome of a cerebrovascular arrest." | 3.69 | Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist. ( Jacobson, KA; Lin, RC; Von Lubitz, DK, 1995) |
| "These findings do not support the hypothesis that coffee or caffeine consumption increases the risk of coronary heart disease or stroke." | 3.68 | Coffee, caffeine, and cardiovascular disease in men. ( Colditz, G; Giovannucci, E; Grobbee, DE; Rimm, EB; Stampfer, M; Willett, W, 1990) |
| "Caffeine intake was related to moderately better cognitive maintenance over 5 years in older women with vascular disorders." | 2.78 | Caffeine and cognitive decline in elderly women at high vascular risk. ( Berr, C; Kang, JH; Ritchie, K; Vercambre, MN, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (60.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vercambre, MN | 1 |
| Berr, C | 1 |
| Ritchie, K | 1 |
| Kang, JH | 1 |
| Kamchatnov, PR | 2 |
| POPEK, K | 1 |
| Sherin, K | 1 |
| Jacobi, G | 1 |
| Ritz, A | 1 |
| Berger, T | 1 |
| Phillis, JW | 1 |
| Von Lubitz, DK | 1 |
| Lin, RC | 1 |
| Jacobson, KA | 1 |
| Tuter, NV | 1 |
| Danilov, AB | 1 |
| Poliakova, LV | 1 |
| Heyden, S | 2 |
| Tyroler, HA | 1 |
| Cassel, JC | 1 |
| Hames, CG | 1 |
| Becker, C | 1 |
| Heiss, G | 1 |
| Longstreth, WT | 1 |
| Nelson, LM | 1 |
| Grobbee, DE | 1 |
| Rimm, EB | 1 |
| Giovannucci, E | 1 |
| Colditz, G | 1 |
| Stampfer, M | 1 |
| Willett, W | 1 |
| Moriyama, K | 1 |
| Osugi, S | 1 |
| Shimamura, K | 1 |
| Sunano, S | 1 |
| Kaiser, H | 1 |
| Mulli, JC | 1 |
| Weber, I | 1 |
| Fabre, J | 1 |
| Stoica, E | 1 |
| Stefanescu, E | 1 |
| Gheorghiu, M | 1 |
| Hauck, A | 1 |
| Wambsganss, E | 1 |
| Buletsa, BA | 1 |
| Pavolotskaia, RSh | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00005122] | 0 participants | Observational | 1958-07-31 | Completed | |||
| [NCT00005182] | 50,000 participants (Actual) | Observational | 1985-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for caffeine and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Therapy of sleep disorders in old age].
Topics: Age Factors; Butyrophenones; Caffeine; Cardiac Glycosides; Cerebrovascular Disorders; Chlormethiazol | 1972 |
[Epidemiology of hypertension].
Topics: Adult; Age Factors; Alcohol Drinking; Blood Pressure; Caffeine; Cerebrovascular Disorders; Coronary | 1973 |
3 trials available for caffeine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Caffeine and cognitive decline in elderly women at high vascular risk.
Topics: Aged; Aging; Caffeine; Central Nervous System Stimulants; Cerebrovascular Disorders; Cognition; Cogn | 2013 |
[The use of vasobral in patients with chronic cerebrovascular disorders].
Topics: Adult; Aged; Caffeine; Cerebrovascular Disorders; Chronic Disease; Dihydroergotoxine; Drug Combinati | 2011 |
[Clinical experiences with a vasoactive combination drug].
Topics: Caffeine; Cerebrovascular Disorders; Clinical Trials as Topic; Estradiol; Humans; Testosterone; Theo | 1965 |
15 other studies available for caffeine and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Vasobral in the treatment of brain lesions: views of physicians and patients].
Topics: Caffeine; Cerebrovascular Disorders; Cognition; Cognition Disorders; Dihydroergotoxine; Drug Combina | 2013 |
THE STUDY OF CHANGES IN THE SO-CALLED SUCCESSIVE CONTRAST IN NEUROLOGY.
Topics: Afterimage; Amphetamine; Arteriosclerosis; Brain Concussion; Brain Injuries; Brain Neoplasms; Bromid | 1964 |
Smoking cessation: the physician's role.
Topics: Asthma; Caffeine; Cerebrovascular Disorders; Coronary Disease; Humans; Male; Motivation; Neoplasms; | 1982 |
[Migraine in children. Clinics, differential diagnosis, and therapy (author's transl)].
Topics: Adolescent; Analgesics; Brain Neoplasms; Caffeine; Cerebral Angiography; Cerebrovascular Disorders; | 1981 |
The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.
Topics: Animals; Behavior, Animal; Caffeine; Carotid Arteries; Cerebral Cortex; Cerebrovascular Disorders; D | 1995 |
Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
Topics: Adenosine; Animals; Brain Ischemia; Caffeine; Cell Survival; Cerebrovascular Circulation; Cerebrovas | 1995 |
[The treatment of a complex regional pain syndrome].
Topics: Acetaminophen; Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Caffeine; Cerebro | 1997 |
Coffee consumption and mortality in a community study--Evans Co., Ga.
Topics: Black People; Caffeine; Cerebrovascular Disorders; Coffee; Coronary Disease; Female; Georgia; Habits | 1976 |
Caffeine and stroke.
Topics: Animals; Caffeine; Cerebrovascular Disorders; Receptors, Purinergic; Rodentia | 1992 |
Coffee, caffeine, and cardiovascular disease in men.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Cerebrovascular Disorders; Coffee; Coronary Disease; | 1990 |
Caffeine-induced contraction in arteries from stroke-prone spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Caffeine; Calcium; Cerebrovascular Disorders; Dose-Response Re | 1989 |
[Effects of coffee during good health and in disease from the medical standpoint].
Topics: Acute Disease; Aged; Blood Pressure; Caffeine; Cerebrovascular Disorders; Coffee; Diabetes Mellitus; | 1974 |
The restoration of the reactivity of higher autonomic centers by pyrithioxin administration in cerebral infarct patients.
Topics: Adult; Blood Glucose; Brain Stem; Caffeine; Cerebrovascular Disorders; Humans; Hypoglycemia; Infarct | 1972 |
[On the facial reflexes of patients with diseases of the nervous system].
Topics: Antihypertensive Agents; Arachnoiditis; Brain Injuries; Caffeine; Central Nervous System Diseases; C | 1969 |
[The effect of caffeine on the arterial and venous pressure in patients with cerebral circulatory disorders].
Topics: Aged; Blood Pressure; Brachial Artery; Caffeine; Cerebrovascular Disorders; Humans; Hypertension; Mi | 1971 |